Biotechnology leads recent analyst upgrades with seven strong buy ratings (PCRX, ALMS, ELDN, LFST, ACET, MAZE, XGN). Financial services (NDAQ, CGBD, VLY) and Energy/Midstream (KMI, HESM, NEXT) also show strong buy momentum on Friday. However, notable downgrades hit mega-caps like TSLA, ISRG, and NOW on Wednesday and Friday, signaling selective caution in growth and financial sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.